Evaluation of portal vein invasion of distal cholangiocarcinoma as borderline resectability

Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pan

(2013) Sohei Satoi et al.   Journal of Hepato-Biliary-Pancreatic Sciences

Influence of preoperative anti-cancer therapy on resectability and perioperative outcomes in patients with pancreatic cancer: Project study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery

(2013) Fuyuhiko Motoi et al.   Journal of Hepato-Biliary-Pancreatic Sciences

Surgical Resection after Downsizing Chemotherapy for Initially Unresectable Locally Advanced Biliary Tract Cancer: A Retrospective Single-center Study

(2012) Atsushi Kato et al.   ANNALS OF SURGICAL ONCOLOGY

The impact of portal vein resection on outcomes for hilar cholangiocarcinoma

(2012) Mechteld C. de Jong et al.   CANCER

Prospective efficacy and safety study of neoadjuvant gemcitabine with capecitabine combination chemotherapy for borderline-resectable or unresectable locally advanced pancreatic adenocarcinoma

(2012) Jae-Lyun Lee et al.   SURGERY

Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy

(2011) Giuliano Barugola et al.   AMERICAN JOURNAL OF SURGERY

Oncological Superiority of Hilar En Bloc Resection for the Treatment of Hilar Cholangiocarcinoma

(2011) Peter Neuhaus et al.   ANNALS OF SURGICAL ONCOLOGY

Borderline resectable pancreatic cancer: rationale for multidisciplinary treatment

(2011) Shinichiro Takahashi et al.   Journal of Hepato-Biliary-Pancreatic Sciences

Hepatectomy With Simultaneous Resection of the Portal Vein and Hepatic Artery for Advanced Perihilar Cholangiocarcinoma

(2010) Masato Nagino et al.   ANNALS OF SURGERY

Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan

(2010) T Okusaka et al.   BRITISH JOURNAL OF CANCER

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

(2010) Juan Valle et al.   NEW ENGLAND JOURNAL OF MEDICINE

The ratio between metastatic and examined lymph nodes is an independent prognostic factor for patients with resectable middle and distal bile duct carcinoma

(2009) Manabu Kawai et al.   AMERICAN JOURNAL OF SURGERY

The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection

(2009) Sae Byeol Choi et al.   JOURNAL OF SURGICAL ONCOLOGY

Surgical Results After Preoperative Chemoradiation Therapy for Patients With Pancreatic Cancer

(2009) Sohei Satoi et al.   PANCREAS

Depth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinoma

(2009) Seung-Mo Hong et al.   SURGERY

Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease

(2008) Matthew H.G. Katz et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS